Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — FY2022 Earnings Presentation
57 slides from Aster Dm Healthcare's earnings presentation, May 24, 2022
Slide 1: Filing cover letter to stock exchanges
May 24, 2022 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scr
Slide 2: Investor Presentation for the quarter and year ended 31st March 2022
Aster @) We'll Treat You Well INVESTOR PRESENTATION For the quarter and year ended 31st March 2022
Slide 3: Disclaimer
Disclaimer * This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; Rapid aligned businesses across Expansion
Slide 6: Business Overview (FY)
Business Overview (FY) 271 GCC : 13 Largest Private Healthcare 5,0658 GCC : 1,160 Hospitals India : 14 Capacity Beds India : 3,905 Presence in 7 Countries 120 GCC : 109 18.6 Mn GCC. : 16.3 Mn Clinics India : 11 Patient Visits India : 2.3 Mn 371 GCC : 240 India : 1313 Pharmacies2 Largest Number of IN
Slide 7: Geographical Footprint
6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(8) C(95) P(217) H(1) H(5) C(2) P(27) L(5) PEC(48) H(4) C(4) L(2) H(3) C(5) P(82) L(4) PEC(52) Oman Qatar Bahrain Jordan Maharashtra Telangana Tamil Nadu H(1) L(1) H(1) P(22) L(1) L(1) H(3) C(6) P(
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview
Slide 9: GCC Hospitals
GCC Hospitals 8 UAE Oman Qatar Saudi
Slide 10: India Hospitals
India Hospitals 9 Kerala Cluster Andhra & Telangana Cluster Karnataka & Maharashtra Cluster
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Owned / Hospitals - India Location Type Planned Beds Expected Completion Year Present Status Leased/O&M
Slide 12: The Aster DM Healthcare Edge
The Aster DM • Healthcare Edge • Robust & • • Expansive Healthcare • Ecosystem • Synergies • • Across Geographies Sturdy • • Performance Record • • Proficient & Experienced Management • • Team Asset-Light Business Model • • De-Risked Business Model • • Touchstone of • Healthcare • Practices
Slide 13: Growth Over the Last 5 Years
Growth Over the Last 5 Years Capacity Beds Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 Hospitals 18 19 24 25 27 27 Clinics 96 101 114 117 115 120 Pharmacies - GCC 202 207 219 238 223 240 Pharmacies -
Slide 14: An Integrated Healthcare Provider
AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY22 Operational Information 1,500+ 273,000+ Cardiovascular IP Discharges Surgeries ~6.2 mn 20,500+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 2,400+ 800+ Joint ~ 8.0 mn Spine Replacements Pharmacy Surgeries Visits 13,600+ 500+ Urology Ca
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Patient Life Cycle Management • Hospitals Clinics Pharmacies • • GCC INDIA • • Hospitals Clinics Resource Talent Management
Slide 17: Digital Health
Digital Health Online Pharmacy (In progress) Virtual Care- Omni-channel app for Patient interface = Technology led approach with Omnichannel Fulfillment = Allows patients to register and book appointments online with the ability to pay in-app, thus saving time and effort Tele-consult with doctors Se
Slide 18: Aster Labs
ORIGIN Aster Labs was established in 2019, with one true preposition of providing THE TRUE TEST. THE TRUE TEST is the brand promise that every analysis will be most accurate —and help doctors to diagnose better and ultimately help patients recover faster. We have successfully served more than 1.5 Mi
Slide 19: Way Forward (India)
(INDIA) Current Way Status Forward ◼ ◼ ◼ ◼ ◼ ◼ ◼ ◼ ◼
Slide 20: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ ➢ ➢ ➢ ➢ Seasonality of Patient Volumes ➢ ➢ ➢ ➢ ➢ Source : World Bank (2020 data) ➢ ➢ 1. globalmediainsight.com 2. worldpopulationreview.com 3. omanobserver.com
Slide 21: Aster - Awards & Service Excellence
20 Aster - Awards & Service Excellence Dr. Azad Moopen - Chairman and Managing Director Alisha Moopen - Deputy Managing Director • • • • • • • • • • • Community Health NABH Accreditation Partner Accreditations (CHAP) Accreditation “Saudi Central Board for Accreditation for Healthcare Aster Hospital
Slide 22: Awards – GCC and India
AHPI Awards CAHO Awards Mother & Child Award G Dubai Quality Award DQA - Medcare Hospital C DQAA C DSES SKEA Gold Initiative Customer QualTech Healthcare Awards Certificate - Arabian Etisalat SMB Awards Experience Live Hospital Federation 2021 I AHPI Awards Times All India Multispecialty N The Econo
Slide 23: Awards and accreditations – GCC and India
HIMSS Accreditation Newsweek World’s G Best Hospitals 2022, UAE Healthcare Asia AHPI Award C IHF LinkedIn Top 5 Aster C Middle East Cleaning, Hygiene GULFCX Awards Dubai Service Excellence I N Healthcare Asia Aster FICCI Awards D AHPI Award No.155 Financial Express’s All India Age Friendly I Healthc
Slide 24: Operational and Financial Overview
OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 25: Clinical Highlights - FY22 Q4
Clinical Highlights - FY22 Q4 India • • • • • GCC • • • • •
Slide 26: Revenue and Profitability Snapshot – FY22 Q4
Revenue and Profitability Snapshot – FY22 Q4 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is 12%, 42% and 112% respectively
Slide 27: Revenue and Profitability Snapshot – FY22
Revenue and Profitability Snapshot – FY22 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is 19%, 39% and 255% respectively
Slide 28: Geography-wise Financial Snapshot – Quarterly
Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 Revenue (₹) 1,910 Cr 2,121 Cr 481 Cr 607 Cr 2,391 Cr 2,728 Cr EBITDA (₹) 289 Cr 384 Cr 32 Cr 79 Cr 321 Cr 463 Cr PAT (Post-NCI) (₹) 132 Cr 215 Cr -27 Cr 11 Cr 105 Cr 226 Cr
Slide 29: Geography-wise Financial Snapshot – FY
Geography – wise Financial – Snapshot – FY GCC INDIA CONSOLIDATED FY21 FY22 FY21 FY22 FY21 FY22 Revenue (₹) 6,954 Cr 7,870 Cr 1,654 Cr 2,384 Cr 8,608 Cr 10,253 Cr EBITDA (₹) 919 Cr 1,130 Cr 144 Cr 353 Cr 1,063 Cr 1,483 Cr PAT (Post-NCI) (₹) 239 Cr 466 Cr -91 Cr 60 Cr 148 Cr 526 Cr
Slide 30: Geography-wise Business Snapshot - Quarterly
Geography – wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 Total Capacity Beds 1,150 1,160 3,757 3,905 4,907 5,065 Operational Beds (Census) 948 923 2,686 2,899 3,634 3,822 Operational Beds (Non-Census) 202 237 632 777 834 1,014 Available
Slide 31: Geography-wise Business Snapshot - FY
Geography – wise Business – Snapshot - FY GCC INDIA CONSOLIDATED FY21 FY22 FY21 FY22 FY21 FY22 Total Capacity Beds 1,150 1,160 3,757 3,905 4,907 5,065 Operational Beds (Census) 948 923 2,686 2,899 3,634 3,822 Operational Beds (Non-Census) 202 237 632 777 834 1,014 Available Capacity Beds 0 0 439 229
Slide 32: India Geography-wise Business Snapshot – Quarterly
Geography – wise Business – Snapshot – Quarterly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 Total Capacity Beds 1,894 2,027 967 1,007 896 871 3,757 3,905 Operational Beds (Census) 1,395 1,575 644 722 647 602 2,686 2,899 Ope
Slide 33: India Geography-wise Business Snapshot - FY
Geography – wise Business – Snapshot - FY KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY21 FY22 FY21 FY22 FY21 FY22 FY21 FY22 Total Capacity Beds 1,894 2,027 967 1,007 896 871 3,757 3,905 Operational Beds (Census) 1,395 1,575 644 722 647 602 2,686 2,899 Operational Beds (Non-Census) 308
Slide 34: Segmental Performance FY22 Q4
India - Unallocated India - Unallocated GCC GCC GCC GCC FY22 Q4 GCC Clinics Hospitals, Clinics & Total GCC Clinics Hospitals, Clinics & Total Hospitals Pharmacies Hospitals Pharmacies and Labs Eliminations and Labs Eliminations No. of Business Units (#) 13 109 240 H-14, C-11, L-14 NA 401 Operational
Slide 35: Segmental Performance FY22
Segmental Performance FY22 India - Unallocated India - Unallocated GCC GCC GCC GCC FY22 FY GCC Clinics Hospitals, & Total GCC Clinics Hospitals, & Total Hospitals Pharmacies Hospitals Pharmacies Clinics and Labs Eliminations Clinics and Labs Eliminations No. of Business Units (#) 13 109 240 H-14, C-
Slide 36: Maturity Wise Hospital Performance – GCC FY22
Maturity Wise Hospital Performance – GCC FY22 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 37: Maturity Wise Hospital Performance – India FY22
Maturity Wise Hospital Performance – India FY22 ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹ ₹
Slide 38: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY22 Q3 FY21 Q4 FY22 Q4 Y-o-Y Gw% Q-o-Q Gw% Revenue from operations 2,650 2,391 2,728 14% 3% Material consumption 746 671 703 Doctors cost 526 470 542 Employee cost (excl. doctors) 522 410 542 Laboratory outsourcing charges 64 14
Slide 39: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY21 FY22 Gw% Revenue from operations 8,608 10,253 19% Material consumption 2,549 2,892 Doctors cost 1,779 2,051 Employee cost (excl. doctors) 1,620 2,029 Laboratory outsourcing charges 276 255 Other expenses 1,322 1,544 EBITDA (
Slide 40: Financial Summary – Balance Sheet & Ratios
Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Mar 31, As at Mar 31, As at Mar 31, Particulars (INR Cr) Consolidated (INR Cr) 2021 2022 2021 2022 LIABILITIES Gross Debt 2,309 2,192 Shareholders Equity 3,372 3,953 Less: Cash, Bank Balance and Current Investments 305 386 Minority Inter
Slide 41: Consol Trends - I
Consol Trends - | 40 Revenue (INR Cr) EBITDA 10,253 1,483 1,258 1,063 8,652 8,608 FY20 FY21 FY22 FY20 FY21 FY22 EBITDA Margin ROCE 14.5% 14.5% 9.7% 74% 5.1% 12.3% FY20 FY21 FY22 FY20 FY21 FY22 EBITDA numbers are Post IndAS116 FY21 numbers have an impact of COVID
Slide 42: Consol Trends - II
Consol Trends - Il Net Debt (excl. Lease Liabilities) (INR Cr) 2,784 2,004 1,806 FY20 FY21 FY22 Net Debt (incl. Lease Liabilities) (INR Cr) 5,416 4,498 4,521 FY20 FY21 FY22 Net Debt (excl. Lease Liabilities)/EBITDA 2.9 27 1.6 FY20 FY21 FY22 * Post IndAS 116 FY21 numbers have an impact of COVID Net D
Slide 43: India: Financial Trends
India: Financial Trends Revenue EBITDA 2384 353 1631 1654 183 144 FY20 FY21 FY22 FY20 FY21 FY22 EBITDA Margin ROCE 14.8% 7.2% 11.3% 8.7% 1.6% 0.0% FY20 FY21 FY22 FY20 FY21 FY22 a2
Slide 44: India Cluster-Wise Trends (Hospitals)
India Cluster-Wise Trends (Hospitals)
Slide 45: Strategy & Leadership
STRATEGY & LEADERSHIP Strategy & Leadership
Slide 46: GCC Strategy
GCC Strategy The pandemic allowed us to reflect and re- invent certain processes at all the locations. Enhanced use of digital means made us explore the power of digitization. We have launched Aster Digital Initiative with a strong focus on foundational and growth levers. Initiatives like Virtual Ca
Slide 47: India Strategy
India Strategy Aster DM Hospitals consistently amongst the top in google rankings and patient endorsements – Visibly growing appreciation in India for quality healthcare, clinical excellence and patient service
Slide 48: ESG: Committed to UN Sustainable Development Goals
ESG: Committed to UN Sustainable Development Goals
Slide 49: Aster Sustainability Report
Aster Sustainability Report 48 Aster’s FY2020-21 sustainability report – showcasing its contribution to multiple stakeholders and UNSDGs • • • •
Slide 50: Aster’s ESG Materiality Assessment
49 Economic Social Environment Aster’s ESG Materiality Assessment • • •
Slide 51: Aster’s commitment to UNSDG
Aster’s commitment to UNSGD 3 fam yf wry ‘canon comace eeuuuy caean waren ne SanTuON srownu 0 cua anne Providing accessible quality healthcareis at the core of our corporate purpose. Aster is providing free of cost healthcare facilities to economically weaker sections such as Community Dialysis Cent
Slide 52: Aster’s alignment with SASB to focus on material issues
Aster’s alignment with SASB to focus on material issues Dimension Issue Environment Social Governance
Slide 53: Aster DM Healthcare - ESG update
Aster DM Healthcare - ESG update Environment Social Governance • • • • • • • • • • • • • • • • • • • • • • • • • •
Slide 54: Aster – ESG Strategy
53 Aster – ESG Strategy Current ESG practices External engagement for gap ESG Policy and ESG Risk ESG Pillars identified in assessment of Aster’s framework approved by the Board level ESG commitment Sustainability Report 2020-21 Aster Board sustainability report against global frameworks Next steps
Slide 55: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen T. J. Wilson Fara Siddiqi Alisha Moopen Sreenath Reddy Dr. Malathi Veneeth Purushotaman Amitabh Johri Brandon Rowberry Dr. Shanila Laiju Dr. Sherbaz Bichu Bala NS Farhan Yasin Dr. Nitesh Shetty Devanand K T Sunil Kumar M R Anindya Chowdhury Ramakrishna D
Slide 56: Aster Board of Directors
Aster Board of Directors Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Shamsudheen Bin Daniel Robert Prof. Biju Varkkey Sridar Arvamudhan Mohideen Mammu Haji Mintz Iyengar Dr. Layla Mohamed Chenayappillil John James Mathew Wayne Earl Hassan Ali Al Marzooqi George Keathley
Slide 57: Thank You
Aster We'll Treat You Well Thank You www.asterdmhealthcare.com Investor Contact: Saurabh Paliwal Email: saurabh.paliwal@asterdmhealthcare.com investors@asterdmhealthcare.com